Multi-center cross-sectional epidemiological study to characterize the prevalence and distribution of lipoprotein(a) levels among patients with established cardiovascular disease
Completed
- Conditions
- hyperlipoproteinemieHyperlipoproteinemiaincreased lipoprotein(a)
- Registration Number
- NL-OMON48235
- Lead Sponsor
- ovartis
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 3700
Inclusion Criteria
1. Signed informed consent must be obtained prior to participation in the study
2. Male and female * 18 to * 80 years of age
3. Established CVD defined as one of the following:
- History of a myocardial infarction (MI) *3 months and *10 years before the
study visit
- History of ischemic stroke * 3 months and * 10 years before the study visit
- Symptomatic PAD (intermitted claudication with ankle-brachial index *0.90
and/or lower limb amputation or re-vascularization due to lower limb ischemia.
Exclusion Criteria
Patients currently enrolled in clinical studies with investigational drugs.
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Proportion of patients with normal and elevated Lp(a) levels in patients with<br /><br>established CVD.</p><br>
- Secondary Outcome Measures
Name Time Method <p>Lp(a) values general and by region/country<br /><br>LDL-C levels (corrected and uncorrected)</p><br>